M&A Advisory
K&L Gates
Full Credential Description
Shields Health Solutions, a specialty pharmacy management company, faced the challenge of securing a full acquisition by Walgreens Boots Alliance (WBA) to consolidate its position in the market. WBA aimed to acquire the remaining approximately 30% stake in Shields for $1.37 billion in cash, following its previous increase of ownership to 70% in September 2021. This strategic move was essential for Shields to enhance its integration as the leading health system-owned specialty pharmacy integrator in the United States. K&L Gates LLP provided tailored legal assistance to Shields, focusing on health care, antitrust, and disclosure matters throughout the acquisition process. The firm’s expertise was crucial in navigating the complexities of the transaction, ensuring compliance with regulatory requirements, and facilitating a smooth negotiation process. The acquisition is expected to close by the end of the 2022 calendar year, positioning Shields for further growth and operational efficiency within the specialty pharmacy sector.
Measurable Results
Successfully completed $1.37B transaction